13F filer · CIK 1649339 ↗
Scion Asset Management
You are looking at Q1 2025. See the latest, Q3 2025 →
Reported value
$199.2M
+157% on the quarter before
Positions
7
6 new · 12 sold out
Top 10
100.0%
of the value
Est. gain
−$898,000
on stocks held all quarter
Est. return
−12.0%
on those stocks since Q4 2024
Positions as of Mar 31, 2025, from Scion Asset Management's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2024. Striped tiles are options.
Largest buys
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- NvidiaPUT~$97.5MNew · 0.0% → 49.0%+900,000 underlying
- AlibabaPUT~$26.4MNew · 0.0% → 13.3%+200,000 underlying
- PDD HoldingsPUT~$23.7MNew · 0.0% → 11.9%+200,000 underlying
- Jd.Com IncPUT~$16.4MNew · 0.0% → 8.3%+400,000 underlying
- Trip Com Group LtdPUT~$12.7MNew · 0.0% → 6.4%+200,000 underlying
- BaiduPUT~$9.2MNew · 0.0% → 4.6%+100,000 underlying
- Lauder Estee Cos Inc~$6.6MAdded · 9.7% → 6.6%+100,000 shares
Largest sells
Since Q4 2024, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Alibaba~$12.7MSold out · 16.4% → 0.0%−150,000 shares
- Baidu~$10.5MSold out · 13.6% → 0.0%−125,000 shares
- Jd.Com Inc~$10.4MSold out · 13.4% → 0.0%−300,000 shares
- Molina Healthcare~$7.3MSold out · 9.4% → 0.0%−25,000 shares
- PDD Holdings~$7.3MSold out · 9.4% → 0.0%−75,000 shares
- Hca Healthcare Inc~$4.5MSold out · 5.8% → 0.0%−15,000 shares
- Bruker Corp~$4.4MSold out · 5.7% → 0.0%−75,000 shares
- V F Corp~$4.3MSold out · 5.5% → 0.0%−200,000 shares
- Magnera Corp~$3.6MSold out · 4.7% → 0.0%−200,000 shares
- Oscar Health Inc~$2.7MSold out · 3.5% → 0.0%−200,000 shares
Holdings
As of Mar 31, 2025. Changes are in shares against Dec 31, 2024, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NvidiaPUTCOM · shares New | 49.0% | $97.5M | — | ||||||||
| AlibabaPUTSPONSORED ADS · shares New | 13.3% | $26.4M | — | ||||||||
| PDD HoldingsPUTSPONSORED ADS · shares New | 11.9% | $23.7M | — | ||||||||
| Jd.Com IncPUTSPON ADS CL A · shares New | 8.3% | $16.4M | — | ||||||||
| Lauder Estee Cos IncCL A · shares +100% · price −12.0% | 6.6% | $13.2M | −$898,000 | ||||||||
| Trip Com Group LtdPUTADS · shares New | 6.4% | $12.7M | — | ||||||||
| BaiduPUTSPON ADR REP A · shares New | 4.6% | $9.2M | — | ||||||||
| Total · 7 positions | 100% | $199.2M | −$898,000 |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2024 to Q1 2025: 1 stocks held throughout, down $898,000 (−12.0%).
- Lauder Estee Cos Inc−$898,000−12%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2025 | Nov 3, 2025 | $1.38B+139% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $578.3M+190% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $199.2M+157% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $77.4M−40% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $129.8M+147% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $52.5M−49% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $103.5M+9% | SEC ↗ |
| Q4 2023 | Feb 16, 2024 (amended) | $94.6M−4% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $99.0M−94% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $1.74B+1,524% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $106.9M+130% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $46.5M+13% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $41.3M+1,148% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $3.3M−98% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $201.4M+170% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $74.5M+78% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $41.7M−98% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $2.08B+54% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $1.35B+503% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $224.7M−32% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $330.3M+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $315.3M+267% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $85.9M+4% | SEC ↗ |
| Q4 2019 | Feb 14, 2020 | $82.3M+38% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $59.6M−36% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $93.6M−5% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $98.2M−5% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $103.5M+193% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $35.4M−22% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $45.5M−11% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $51.1M | SEC ↗ |